Our human clinical sample data showing heterogeneous tumor cell clones with heterogeneous exhausted CD8+ T-cell clonal infiltration suggest that the efficacy of immunotherapies can be different among heterogeneous lesions in the same patient. The gene discussed is CD8A; the disease is neoplasm.